Search
There were a total of 29 results for your search.
Director's vision
Pirbright has seen immense change and exceptional scientific achievement in recent years, bringing major breakthroughs in our understanding of virus and host interaction. Many have been achieved...
Type: Page
Pigs ideal for assessing flu antibody therapies, say Pirbright scientists
Studies undertaken at The Pirbright Institute in collaboration with Inovio Pharmaceuticals have shown that pigs can be used to assess whether influenza antibody therapies are effective, which could...
Type: News
Pirbright study to improve the production and supply of foot-and-mouth disease vaccine
Researchers at The Pirbright Institute have secured almost $1.5 million from the Bill and Melinda Gates Foundation to fund the development of improved foot-and-mouth disease (FMD) vaccines for East...
Type: News
Pigs as universal flu vaccine models
Researchers from The Pirbright Institute collaborated with the University of Oxford and the National Institutes of Health, USA, to show that S-FLU, a universal flu vaccine candidate, induces...
Type: News
Pirbright scientists use ‘molecular magnets’ to discover FMD virus segments that could improve vaccine effectiveness
Recent research from The Pirbright Institute has revealed new parts of the foot-and-mouth disease virus (FMDV) that stimulate an immune response, which could be used to inform the design of improved...
Type: News
Pirbright and VIDO expands collaboration to advance vaccine manufacturing
The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) at The Pirbright Institute has signed a memorandum of understanding (MOU) with The University of Saskatchewan’s (USask) Vaccine...
Type: News
Pirbright generates first pig flu antibodies that could improve human treatments and guide flu vaccine selection
The Pirbright Institute has generated the first pig antibodies against swine influenza (flu) that protect against infection and recognise the same parts of the flu virus as human antibodies. This...
Type: News
Pirbright reveals true cost of goat plague vaccination campaigns
A study led by The Pirbright Institute has created the first framework for determining the true cost of peste des petits ruminants (PPR) vaccine campaigns based on case studies in Ethiopia. PPR, also...
Type: News
Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points
One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome chinks in its armour as it evolves, say an international...
Type: News
Pirbright scientists show gene editing tool could crack down on diseases spread by southern house mosquitoes
A new gene editing tool has been successfully applied to the southern house mosquito by researchers at The Pirbright Institute. This paves the way for genetic control methods that could prevent the...
Type: News